Clinical Trials Logo
  1. Home
  2. T2D
  3. NCT05980754

Clinical Study on Exploring High Risk Factors Inducing the Progress of Diabetes

T2D Clinical Trial

Official title:
Clinical Study on Exploring High Risk Factors Inducing the Progress of Diabetes

Clinical Trial Summary

Explore the high related factors of impaired glucose tolerance through descriptive statistics and analysis of variance.

Clinical Trial Description

This study is a cross-sectional study planned to include healthy individuals with a BMI within the normal range (18.5<BMI<24 kg/m2) (HbA1c ≤ 5.6%, n=18), pre diabetic patients (5.7% ≤ HbA1c ≤ 6.4%, n=36), and T2DM patients (HbA1c ≥ 6.5%, n=36) among individuals who meet the inclusion criteria and undergo annual physical examinations at the Physical Examination Center of the Third Hospital of Beijing Medical University. Collect the examination values related to demography and glucose metabolism balance of physical examination items, and carry out magnetic resonance imaging (MRI) imaging examination and oral glucose tolerance test (OGTT) results. Explore the high related factors of impaired glucose tolerance through descriptive statistics and analysis of variance. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05980754
Study type Observational [Patient Registry]
Source Peking University Third Hospital
Contact
Status Not yet recruiting
Phase
Start date May 20, 2024
Completion date December 30, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT03194152 - Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population N/A
Enrolling by invitation NCT05760677 - Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM Phase 1
Recruiting NCT04501341 - BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients Phase 1/Phase 2
Completed NCT03195400 - Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
Active, not recruiting NCT05662332 - A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) Phase 3
Recruiting NCT05536804 - A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes Phase 2
Completed NCT04011904 - The Role of Traditional or Western Diet in the TBC1D4 Gene on Glucose Homeostasis in Greenland Inuits N/A
Active, not recruiting NCT05260021 - A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both Phase 3